c-Abl tyrosine kinase modulates tau pathology and Cdk5 phosphorylation in AD transgenic mice

Culturing hippocampal neurons

Kaech, S., & Banker, G. A. (2006) · Nature Protocols · doi:10.1038/nprot.2006.356 · Cited by 1,705 · see citing works

Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration

Patrick, G. N., Zukerberg, L. R., Nikolić, M., de la Monte, S. M., Dikkes, P., & Tsai, L. (1999) · Nature · doi:10.1038/45159 · Cited by 1,541 · see citing works

Deciphering the Molecular Basis of Memory Failure in Alzheimer's Disease

Walsh, D. M., & Selkoe, D. J. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.010 · Cited by 1,207 · see citing works

The GSK3 hypothesis of Alzheimer’s disease

Hooper, C., Killick, R., & Lovestone, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05194.x · Cited by 1,191 · see citing works

Culturing hippocampal neurons.

Tanaka, H. (2002) · Folia Pharmacologica Japonica · doi:10.1254/fpj.119.163 · Cited by 1,141 · see citing works

Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles

Cruz, J. C., Tseng, H.-C., Goldman, J. A., Shih, H., & Tsai, L.-H. (2003) · Neuron · doi:10.1016/s0896-6273(03)00627-5 · Cited by 609 · see citing works

Regulation of the c-Abl and Bcr–Abl tyrosine kinases

Hantschel, O. D., & Superti‐Furga, G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1280 · Cited by 491 · see citing works

A Hundred Years of Alzheimer's Disease Research

Hardy, J. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.016 · Cited by 467 · see citing works

Essential Roles for the Abl and Arg Tyrosine Kinases in Neurulation

Koleske, A. J., Gifford, A. M., Scott, M. L., Nee, M., Bronson, R. T., Miczek, K. A., & Baltimore, D. (1998) · Neuron · doi:10.1016/s0896-6273(00)80646-7 · Cited by 397 · see citing works

Cables Links Cdk5 and c-Abl and Facilitates Cdk5 Tyrosine Phosphorylation, Kinase Upregulation, and Neurite Outgrowth

Zukerberg, L. R., Patrick, G. N., Nikolić, M., Humbert, S., Wu, C., Lanier, L. M., Gertler, F. B., Vidal, M., Etten, R. A. V., & Tsai, L. (2000) · Neuron · doi:10.1016/s0896-6273(00)81200-3 · Cited by 395 · see citing works

Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity.

Takashima, A., Noguchi, K., Sato, K., Hoshino, T., & Imahori, K. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7789 · Cited by 381 · see citing works

Deregulation of Cdk5 in a Mouse Model of ALS

Nguyen, M. D., Larivière, R., & Julien, J. (2001) · Neuron · doi:10.1016/s0896-6273(01)00268-9 · Cited by 339 · see citing works

Stable Complexes Involving Acetylcholinesterase and Amyloid-β Peptide Change the Biochemical Properties of the Enzyme and Increase the Neurotoxicity of Alzheimer’s Fibrils

Alvarez, A. R., Alarcón, R., Opazo, C., Campos, E. O., Muñoz, F. J., Calderón, F. H., Dajas, F., Gentry, M. K., Doctor, B. P., Mello, F. G. D., et al. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03213.1998 · Cited by 320 · see citing works

p35, the Neuronal-specific Activator of Cyclin-dependent Kinase 5 (Cdk5) Is Degraded by the Ubiquitin-Proteasome Pathway

Patrick, G. N., Zhou, P., Kwon, Y. T., Howley, P. M., & Tsai, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.24057 · Cited by 311 · see citing works

Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease

Smith, P. D., Crocker, S. J., Jackson-Lewis, V. R., Jordan‐Sciutto, K. L., Hayley, S. P., Mount, M. P., O'Hare, M. J., Callaghan, S. M., Slack, R. S., Przedborski, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2232515100 · Cited by 310 · see citing works

Cyclin-dependent kinase 5 governs learning and synaptic plasticity via control of NMDAR degradation

Hawasli, A. H., Benavides, D. R., Nguyen, C. T. N., Kansy, J. W., Hayashi, K., Chambon, P., Greengard, P., Powell, C. M., Cooper, D., & Bibb, J. A. (2007) · Nature Neuroscience · doi:10.1038/nn1914 · Cited by 292 · see citing works

Cdk5 activation induces hippocampal CA1 cell death by directly phosphorylating NMDA receptors

Wang, J., Liu, S., Fu, Y., Wang, J. H.-C., & Lu, Y. (2003) · Nature Neuroscience · doi:10.1038/nn1119 · Cited by 270 · see citing works

Cdk5 deregulation in the pathogenesis of Alzheimer's disease

Cruz, J. C., & Tsai, L.-H. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.07.001 · Cited by 258 · see citing works

Calcium‐Activated Neutral Proteinase (Calpain) System in Aging and Alzheimer's Diseasea

Nixon, R. A., Saito, K., Grynspan, F., Griffin, W. R., Katayama, S., Honda, T., Mohan, P. S., Shea, T. B., & Beermann, M. L. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb44402.x · Cited by 256 · see citing works

Critical Role of CDK5 and Polo-like Kinase 2 in Homeostatic Synaptic Plasticity during Elevated Activity

Seeburg, D. P., Feliú-Mójer, M. I., Gaiottino, J., Pak, D. T. S., & Sheng, M. (2008) · Neuron · doi:10.1016/j.neuron.2008.03.021 · Cited by 230 · see citing works

Inhibition of tau phosphorylating protein kinase cdk5 prevents β‐amyloid‐induced neuronal death

Alvarez, A. R., Toro, R., Cáceres, A., & Maccioni, R. B. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01279-x · Cited by 228 · see citing works

Expression of Ca2+-Permeable AMPA Receptor Channels Primes Cell Death in Transient Forebrain Ischemia

Liu, S., Lau, L. W., Wei, J., Zhu, D., Zou, S., Sun, H.-S., Fu, Y., Liu, F., & Lu, Y. (2004) · Neuron · doi:10.1016/j.neuron.2004.06.017 · Cited by 208 · see citing works

Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect?

Dickson, D. W. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22317 · Cited by 201 · see citing works

A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains

Tseng, H.-C., Zhou, Y., Shen, Y., & Tsai, L.-H. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02934-4 · Cited by 198 · see citing works

Tyrosine 394 Is Phosphorylated in Alzheimer's Paired Helical Filament Tau and in Fetal Tau with c-Abl as the Candidate Tyrosine Kinase

Derkinderen, P., Scales, T. M. E., Hanger, D. P., Leung, K., Byers, H. L., Ward, M. A., Lenz, C., Price, C., Bird, I. N., Perera, T. P. S., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1487-05.2005 · Cited by 186 · see citing works

Activation of the repulsive receptor Roundabout inhibits N-cadherin-mediated cell adhesion

Rhee, J., Mahfooz, N. S., Arregui, C. O., Lilien, J. E., Balsamo, J., & VanBerkum, M. F. A. (2002) · Nature Cell Biology · doi:10.1038/ncb858 · Cited by 183 · see citing works

Synaptic Roles of Cdk5: Implications in Higher Cognitive Functions and Neurodegenerative Diseases

Cheung, Z. H., Fu, A. K. Y., & Ip, N. Y. (2006) · Neuron · doi:10.1016/j.neuron.2006.02.024 · Cited by 182 · see citing works

Selective Phosphorylation of Adult Tau Isoforms in Mature Hippocampal Neurons Exposed to Fibrillar Aβ

Ferreira, A., Lu, Q., Orecchio, L., & Kosik, K. S. (1997) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1997.0615 · Cited by 178 · see citing works

Deregulation of cdk5, Hyperphosphorylation, and Cytoskeletal Pathology in the Niemann–Pick Type C Murine Model

Bu, B., Li, J., Davies, P., & Vincent, I. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06515.2002 · Cited by 178 · see citing works

A Jekyll and Hyde kinase: roles for Cdk5 in brain development and disease

Cruz, J. C., & Tsai, L. (2004) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2004.05.002 · Cited by 170 · see citing works

Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain

Lee, K., Clark, A. W., Rosales, J. L., Chapman, K. R., Fung, T. S., & Johnston, R. N. (1999) · Neuroscience Research · doi:10.1016/s0168-0102(99)00026-7 · Cited by 168 · see citing works

Cdk5 Regulates the Phosphorylation of Tyrosine 1472 NR2B and the Surface Expression of NMDA Receptors

Zhang, S., Edelmann, L., Liu, J., Crandall, J. E., & Morabito, M. A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1900-07.2008 · Cited by 168 · see citing works

Modulation of the F-actin cytoskeleton by c-Abl tyrosine kinase in cell spreading and neurite extension

Woodring, P. J., Litwack, E. D., O’Leary, D. D. M., Lucero, G. R., Wang, J. Y. J., & Hunter, T. R. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200110014 · Cited by 164 · see citing works

Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease

Grynspan, F., Griffin, W. R., Cataldo, A. M., Katayama, S., & Nixon, R. A. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00384-3 · Cited by 156 · see citing works

STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer's β-amyloid deposits

Cancino, G. I., Toledo, E. M., Leal, N. R., Hernández, D. E., Yévenes, L. F., Inestrosa, N. C., & Alvarez, A. R. (2008) · Brain · doi:10.1093/brain/awn125 · Cited by 147 · see citing works

Calpain‐mediated degradation of p35 to p25 in postmortem human and rat brains

Taniguchi, S., Fujita, Y., Hayashi, S., Kakita, A., Takahashi, H., Murayama, S., Saido, T. C., Hisanaga, S., Iwatsubo, T., & Hasegawa, M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(00)02431-5 · Cited by 141 · see citing works

Cyclin‐dependent kinase 5 in synaptic plasticity, learning and memory

Angelo, M., Plattner, F., & Giese, K.-P. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04040.x · Cited by 133 · see citing works

Multiple cyclin-dependent kinases signals are critical mediators of ischemia/hypoxic neuronal death in vitro and in vivo

Rashidian, J., Iyirhiaro, G. O., Aleyasin, H., Rios, M., Vincent, I. J., Callaghan, S. M., Bland, R. J., Slack, R. S., During, M. J., & Park, D. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500099102 · Cited by 133 · see citing works

Activation of the neuronal c-Abl tyrosine kinase by amyloid-β-peptide and reactive oxygen species

Alvarez, A. R., Sandoval, P. C., Leal, N. R., Castro, P. U., & Kosik, K. S. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.06.007 · Cited by 125 · see citing works

β-sheet breaker peptide prevents Aβ-induced spatial memory impairments with partial reduction of amyloid deposits

Chacón, M. A., Barría, M. I., Soto, C. A., & Inestrosa, N. C. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001516 · Cited by 125 · see citing works

A Cdk5–p35 Stable Complex Is Involved in the β-Amyloid-Induced Deregulation of Cdk5 Activity in Hippocampal Neurons

Alvarez, A. R., Muñoz, J. P., & Maccioni, R. B. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5152 · Cited by 125 · see citing works

Cdk5, a therapeutic target for Alzheimer's disease?

Tsai, L., Lee, M.-S., & Cruz, J. C. (2003) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.11.019 · Cited by 122 · see citing works

Imatinib therapy blocks cerebellar apoptosis and improves neurological symptoms in a mouse model of Niemann‐Pick type C disease

Alvarez, A. R., Klein, A. D., Castro, J., Cancino, G. I., Amigo, J. D., Mosqueira, M., Vargas, L. M., Yévenes, L. F., Bronfman, F. C., & Zanlungo, S. (2008) · The FASEB Journal · doi:10.1096/fj.07-102715 · Cited by 106 · see citing works

Cdk5: One of the links between senile plaques and neurofibrillary tangles?

Lee, M.-S., & Tsai, L. (2003) · Journal of Alzheimer s Disease · doi:10.3233/jad-2003-5207 · Cited by 104 · see citing works

Crosstalk between Cdk5 and GSK3β: Implications for Alzheimer's Disease

Engmann, O. (2009) · Frontiers in Molecular Neuroscience · doi:10.3389/neuro.02.002.2009 · Cited by 98 · see citing works

c-Abl stabilizes p73 by a phosphorylation-augmented interaction.

Tsai, K. K., & Yuan, Z.-M. (2003) · PubMed · Cited by 95 · see citing works

Regulation of neuronal morphogenesis and synaptic function by Abl family kinases

Moresco, E. M. Y., & Koleske, A. J. (2003) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2003.08.002 · Cited by 90 · see citing works

Altered subcellular distribution of c-Abl in Alzheimer’s disease

Jing, Z., Caltagarone, J., & Bowser, R. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1062 · Cited by 83 · see citing works

The Relationship between Amyloid and Tau

Hardy, J. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:2:203 · Cited by 80 · see citing works

Abl deregulates Cdk5 kinase activity and subcellular localization in Drosophila neurodegeneration

Lin, H., Lin, T.-Y., & Juang, J. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402033 · Cited by 79 · see citing works

p25 protein in neurodegeneration

Yoo, B. C., & Lübec, G. (2001) · Nature · doi:10.1038/35081146 · Cited by 79 · see citing works

Involvement of cyclin dependent kinase5 activator p25 on tau phosphorylation in mouse brain

Takashima, A., Murayama, M., Yasutake, K., Takahashi, H., Yokoyama, M., & Ishiguro, K. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01864-x · Cited by 78 · see citing works

The roles of cyclin‐dependent kinase 5 in dendrite and synapse development

Cheung, Z. H., & Ip, N. Y. (2007) · Biotechnology Journal · doi:10.1002/biot.200700056 · Cited by 70 · see citing works

Nuclear c-Abl is a COOH-terminal repeated domain (CTD)-tyrosine (CTD)-tyrosine kinase-specific for the mammalian RNA polymerase II: possible role in transcription elongation.

Baskaran, R., Escobar, S. R., & Wang, J. Y. J. (1999) · PubMed · Cited by 67 · see citing works

Abl Family Nonreceptor Tyrosine Kinases Modulate Short-Term Synaptic Plasticity

Moresco, E. M. Y., Scheetz, A. J., Bornmann, W. G., Koleske, A. J., & Fitzsimonds, R. M. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00892.2002 · Cited by 61 · see citing works

Gene expression profiling following maternal deprivation: Involvement of the brain renin-angiotensin system

Liebl, C. (2009) · Frontiers in Molecular Neuroscience · doi:10.3389/neuro.02.001.2009 · Cited by 60 · see citing works

Enterovirus 71 triggering of neuronal apoptosis through activation of Abl-Cdk5 signalling

Chen, T., Lai, Y., Yu, C., & Juang, J. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00988.x · Cited by 59 · see citing works

Cytoskeletal mechanisms of neuronal degeneration

Brandt, R. (2001) · Cell and Tissue Research · doi:10.1007/s004410000334 · Cited by 52 · see citing works

Alternative roles for Cdk5 in learning and synaptic plasticity

Hawasli, A. H., & Bibb, J. A. (2007) · Biotechnology Journal · doi:10.1002/biot.200700093 · Cited by 52 · see citing works

Brain armadillo protein δ‐catenin interacts with Abl tyrosine kinase and modulates cellular morphogenesis in response to growth factors

Lu, Q., Mukhopadhyay, N. K., Griffin, J. D., Paredes, M. F., Medina, M., & Kosik, K. S. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10151 · Cited by 51 · see citing works

Significance and mechanism of alzheimer neurofibrillary degeneration and therapeutic targets to inhibit this lesion

Iqbal, K., Alonso, A. D. C., El-Akkad, E., Gong, C., Haque, N., Khatoon, S., Pei, J.-J., Tsujio, I., Wang, J., & Grundke, I. (2002) · Journal of Molecular Neuroscience · doi:10.1007/s12031-002-0017-3 · Cited by 49 · see citing works

Requirement of caspase-mediated cleavage of c-Abl during stress-induced apoptosis

Machuy, N., Rajalingam, K., & Rudel, T. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401336 · Cited by 49 · see citing works

Cooperative Roles of c-Abl and Cdk5 in Regulation of p53 in Response to Oxidative Stress

Lee, J., Jeong, M.-W., Kim, W., Choi, Y. H., & Kim, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706201200 · Cited by 42 · see citing works

Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy

Borghi, R., Giliberto, L., Assini, A., Delacourte, A., Perry, G. L., Smith, M. A., Strocchi, P. M., Zaccheo, D., & Tabaton, M. (2002) · Neurology · doi:10.1212/wnl.58.4.589 · Cited by 37 · see citing works

p25 protein in neurodegeneration

Patrick, G. N., Zukerberg, L. R., Nikolić, M., de la Monte, S. M., Dikkes, P., & Tsai, L. (2001) · Nature · doi:10.1038/35081149 · Cited by 23 · see citing works

Antipodal Effects of p25 on Synaptic Plasticity, Learning, and Memory—Too Much of a Good Thing Is Bad

LaFerla, F. M., & Kitazawa, M. (2005) · Neuron · doi:10.1016/j.neuron.2005.11.022 · Cited by 9 · see citing works

Oxidative stress, mitochondrial damage and neurodegenerative diseases.

Guo, C., Sun, L., Chen, X., & Zhang, D. (2013) · PubMed Central · doi:10.3969/j.issn.1673-5374.2013.21.009 · Cited by 1,308 · see citing works

The importance of tau phosphorylation for neurodegenerative diseases

Noble, W., Hanger, D. P., Miller, C. C. J., & Lovestone, S. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00083 · Cited by 475 · see citing works

The Role of Cdk5 in Alzheimer’s Disease

Liu, S., Wang, C., Jiang, T., Tan, L., Xing, A., & Yu, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9369-x · Cited by 273 · see citing works

Drug repositioning: Progress and challenges in drug discovery for various diseases

Hua, Y., Dai, X., Xu, Y., Xing, G., Liu, H., Lu, T., Chen, Y., & Zhang, Y. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114239 · Cited by 232 · see citing works

Cdk5 activity in the brain – multiple paths of regulation

Shah, K., & Lahiri, D. K. (2014) · Journal of Cell Science · doi:10.1242/jcs.147553 · Cited by 196 · see citing works

The role of tau kinases in Alzheimer's disease.

Dolan, P. J., & Johnson, G. V. W. (2010) · PubMed · Cited by 174 · see citing works

Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of A lzheimer's Disease

Tapia‐Rojas, C., Aránguiz, F. C., Varela‐Nallar, L., & Inestrosa, N. C. (2015) · Brain Pathology · doi:10.1111/bpa.12255 · Cited by 168 · see citing works

Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer’s disease? From preclinical studies to the clinical trials

Basheer, N., Smolek, T., Hassan, I., Liu, F., Iqbal, K., Zilka, N., & Novak, P. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02113-z · Cited by 159 · see citing works

Tyrosine kinase inhibition increases functional parkin‐Beclin‐1 interaction and enhances amyloid clearance and cognitive performance

Lonskaya, I., Hebron, M. L., Desforges, N. M., Franjie, A., & Moussa, C. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302771 · Cited by 139 · see citing works

Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice

Liu, H., Zhao, G., Zhang, H., & Li-de, S. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.08.008 · Cited by 141 · see citing works

c-Abl in Neurodegenerative Disease

Schlatterer, S. D., Acker, C. M., & Davies, P. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9588-1 · Cited by 126 · see citing works

The c-Abl-MST1 Signaling Pathway Mediates Oxidative Stress-Induced Neuronal Cell Death

Xiao, L., Chen, D., Hu, P., Wu, J., Liu, W., Zhao, Y. L., Cao, M., Fang, Y., Bi, W., Zheng, Z., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0035-11.2011 · Cited by 123 · see citing works

Regulation and role of cyclin‐dependent kinase activity in neuronal survival and death

Hisanaga, S., & Endo, R. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07050.x · Cited by 117 · see citing works

Inhibition of Src kinase activity attenuates amyloid associated microgliosis in a murine model of Alzheimer’s disease

Manocha, G. D., & Combs, C. K. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-117 · Cited by 119 · see citing works

Nuclear envelope dysfunction and its contribution to the aging process

Martins, F., Sousa, J., Pereira, C. D., Silva, O. A. B. D. C. E., & Rebelo, S. (2020) · Aging Cell · doi:10.1111/acel.13143 · Cited by 107 · see citing works

Amyloid-β oligomers stimulate microglia through a tyrosine kinase dependent mechanism

Manocha, G. D., Floden, A. M., & Combs, C. K. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.027 · Cited by 104 · see citing works

Nilotinib restores memory function by preventing dopaminergic neuron degeneration in a mouse model of Alzheimer’s Disease

La Barbera, L., Vedele, F., Nobili, A., Krashia, P., Spoleti, E., Latagliata, E. C., Cutuli, D., Cauzzi, E., Marino, R., Viscomi, M. T., et al. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.102031 · Cited by 98 · see citing works

Targeted Dephosphorylation of Tau by Phosphorylation Targeting Chimeras (PhosTACs) as a Therapeutic Modality

Hu, Z., Chen, P.-H., Li, W., Douglas, T., Hines, J., Liu, Y., & Crews, C. M. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.2c11706 · Cited by 98 · see citing works

Reactive oxygen species trigger motoneuron death in non-cell-autonomous models of ALS through activation of c-Abl signaling

Rojas, F., González, D., Cortés, N., Ampuero, E., Hernández, D. E., Fritz, E., Abarzúa, S., Martinez, A. N., Elorza, Á. A., Alvarez, A. R., et al. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00203 · Cited by 95 · see citing works

c-Abl Stabilizes HDAC2 Levels by Tyrosine Phosphorylation Repressing Neuronal Gene Expression in Alzheimer’s Disease

Gonzalez-Zuñiga, M., Contreras, P. S., Estrada, L. D., Chamorro, D., Villagra, A., Zanlungo, S., Seto, E., & Alvarez, A. R. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.08.013 · Cited by 91 · see citing works

EphA4 Activation of c-Abl Mediates Synaptic Loss and LTP Blockade Caused by Amyloid-β Oligomers

Vargas, L. M., Leal, N. R., Estrada, L. D., González, A., Serrano, F. G., Araya, K. A., Gysling, K., Inestrosa, N. C., Pasquale, E. B., & Alvarez, A. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092309 · Cited by 85 · see citing works

The c-Abl inhibitor, Radotinib HCl, is neuroprotective in a preclinical Parkinson’s disease mouse model

Lee, S., Kim, S., Park, Y. J., Yun, S. P., Kwon, S., Kim, D., Kim, D.-Y., Shin, J. S., Cho, D. J., Lee, G. Y., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy143 · Cited by 81 · see citing works

c-Abl–p38α signaling plays an important role in MPTP-induced neuronal death

Wu, R., Chen, H., Ma, J., He, Q., Huang, Q., Liu, Q., Li, M., & Yuan, Z. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.135 · Cited by 82 · see citing works

Mediators of tau phosphorylation in the pathogenesis of Alzheimer’s disease

Hanger, D. P., Seereeram, A., & Noble, W. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.104 · Cited by 98 · see citing works

Protein kinases in neurodegenerative diseases: current understandings and implications for drug discovery

Wu, X., Yang, Z., Zou, J., Gao, H., Shao, Z., Li, C., & Lei, P. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02179-x · Cited by 88 · see citing works

Hypoxia Increases Aβ-Induced Tau Phosphorylation by Calpain and Promotes Behavioral Consequences in AD Transgenic Mice

Gao, L., Tian, S., Gao, H.-H., & Xu, Y.-Y. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-9966-y · Cited by 80 · see citing works

Phosphorylated tau potentiates Aβ-induced mitochondrial damage in mature neurons

Quintanilla, R. A., Rommy von Bernhardi, M., Godoy, J. A., Inestrosa, N. C., & Johnson, G. V. W. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.016 · Cited by 72 · see citing works

Morin reverses neuropathological and cognitive impairments in APPswe/PS1dE9 mice by targeting multiple pathogenic mechanisms

Du, Y., Qu, J., Zhang, W., Bai, M., Zhou, Q., Zhang, Z., Li, Z., & Miao, J. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.04.008 · Cited by 72 · see citing works

Anti-Diabetes Drug Pioglitazone Ameliorates Synaptic Defects in AD Transgenic Mice by Inhibiting Cyclin-Dependent Kinase5 Activity

Chen, J., Li, S., Sun, W.-S., & Li, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123864 · Cited by 70 · see citing works

Amyloid-β oligomers synaptotoxicity: The emerging role of EphA4/c-Abl signaling in Alzheimer's disease

Vargas, L. M., Cerpa, W. F., Muñoz, F. J., Zanlungo, S., & Alvarez, A. R. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.01.023 · Cited by 69 · see citing works

Cdk5 at crossroads of protein oligomerization in neurodegenerative diseases: facts and hypotheses

Wilkaniec, A., Czapski, G. A., & Adamczyk, A. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13365 · Cited by 68 · see citing works

Neuronal c-Abl Overexpression Leads to Neuronal Loss and Neuroinflammation in the Mouse Forebrain

Schlatterer, S. D., Tremblay, M. A., Acker, C. M., & Davies, P. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-102025 · Cited by 65 · see citing works

Tetrahydrohyperforin prevents cognitive deficit, Aβ deposition, tau phosphorylation and synaptotoxicity in the APPswe/PSEN1ΔE9 model of Alzheimer's disease: a possible effect on APP processing

Inestrosa, N. C., Tapia‐Rojas, C., Griffith, T. N., Carvajal, F. J., Benito, M. J., Rivera-Dictter, A., Alvarez, A. R., Serrano, F. G., Hancke, J. L., Burgos, P. V., et al. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.19 · Cited by 65 · see citing works

Parkinson’s Disease: A Complex Interplay of Mitochondrial DNA Alterations and Oxidative Stress

Ciccone, S., Maiani, E., Bellusci, G., Diederich, M. F., & Gonfloni, S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14022388 · Cited by 64 · see citing works

c-Abl Tyrosine Kinase Mediates Neurotoxic Prion Peptide-Induced Neuronal Apoptosis via Regulating Mitochondrial Homeostasis

Pan, B., Yang, L., Wang, J., Wang, Y., Wang, J., Zhou, X., Yin, X., Zhang, Z., & Zhao, D. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8646-4 · Cited by 61 · see citing works

Valproate reduces tau phosphorylation via cyclin-dependent kinase 5 and glycogen synthase kinase 3 signaling pathways

Hu, J.-P., Xie, J., Wang, C., Wang, T., Wang, X., Wang, S., Teng, W., & Wang, Z. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.03.006 · Cited by 59 · see citing works

Regulation of Neuronal Cell Death by c-Abl-Hippo/MST2 Signaling Pathway

Liu, W., Wu, J., Xiao, L., Bai, Y., Qu, A., Zheng, Z., & Yuan, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036562 · Cited by 60 · see citing works

Hyperphosphorylation of tau protein by calpain regulation in retina of Alzheimer's disease transgenic mouse

Zhao, H., Chang, R., Che, H., Wang, J., Yang, L., Wei, F., Xia, Y., Li, N., Ma, Q., & Wang, X. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.06.026 · Cited by 52 · see citing works

Tau clearance improves astrocytic function and brain glutamate-glutamine cycle

Hebron, M. L., Javidnia, M., & Moussa, C. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.06.005 · Cited by 49 · see citing works

Expanding spectrum of anticancer drug, imatinib, in the disorders affecting brain and spinal cord

Kumar, M., Kulshrestha, R., Singh, N., & Jaggi, A. S. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.03.014 · Cited by 46 · see citing works

c-Abl Inhibition Activates TFEB and Promotes Cellular Clearance in a Lysosomal Disorder

Contreras, P. S., Tapía, P., González-Hódar, L., Peluso, I., Soldati, C., Napolitano, G., Matarese, M., Heras, M. L., Valls, C., Martinez, A. N., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101691 · Cited by 46 · see citing works

Mechanistic Insights for Drug Repurposing and the Design of Hybrid Drugs for Alzheimer’s Disease

Padhi, D., & Govindaraju, T. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00335 · Cited by 47 · see citing works

Targeting dementias through cancer kinases inhibition

Fagiani, F., Lanni, C., Racchi, M., & Govoni, S. (2020) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12044 · Cited by 43 · see citing works

STI571 protects neuronal cells from neurotoxic prion protein fragment-induced apoptosis

Yao-qian, P., Sun, L., Wang, J., Fu, W., Fu, Y., Wang, J., Tong, Y., & Pan, B. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.01.029 · Cited by 40 · see citing works

Altered distribution of the EphA4 kinase in hippocampal brain tissue of patients with Alzheimer¿s disease correlates with pathology

Rosenberger, A. F. N., Rozemüller, A. J. M., van der Flier, W. M., Scheltens, P., van der Vies, S. M., & Hoozemans, J. J. M. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0079-9 · Cited by 39 · see citing works

Dysfunction of the ubiquitin ligase E3A Ube3A/E6-AP contributes to synaptic pathology in Alzheimer’s disease

Olabarria, M., Pasini, S., Corona, C., Robador, P. A., Song, C., Patel, H., & Lefort, R. (2019) · Communications Biology · doi:10.1038/s42003-019-0350-5 · Cited by 39 · see citing works

Tau‐targeting nanoparticles for treatment of Alzheimer's disease

Pawar, S., Rauf, M. A., Abdelhady, H. G., & Iyer, A. K. (2024) · Exploration · doi:10.1002/exp.20230137 · Cited by 41 · see citing works

Lentivirus-Mediated HDAC3 Inhibition Attenuates Oxidative Stress in APPswe/PS1dE9 Mice

Yu, L.-J., Liu, Y., Jin, Y., Cao, X., Chen, J., Jin, J.-L., Gu, Y., Bao, X.-Y., Ren, Z., Xu, Y., et al. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-170844 · Cited by 36 · see citing works

Post-translational modifications within tau paired helical filament nucleating motifs perturb microtubule interactions and oligomer formation

Acosta, D. M., Mancinelli, C. D., Bracken, C., & Eliezer, D. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101442 · Cited by 35 · see citing works

The Role of c-Abl Tyrosine Kinase in Brain and Its Pathologies

Motaln, H., & Rogelj, B. (2023) · Cells · doi:10.3390/cells12162041 · Cited by 32 · see citing works

High NaCl–induced activation of CDK5 increases phosphorylation of the osmoprotective transcription factor TonEBP/OREBP at threonine 135, which contributes to its rapid nuclear localization

Gallazzini, M., Heussler, G. E., Kunin, M., Izumi, Y., Burg, M. B., & Ferraris, J. D. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-08-0681 · Cited by 32 · see citing works

Cdk5: A main culprit in neurodegeneration

Gupta, K. K., & Singh, S. K. (2019) · International Journal of Neuroscience · doi:10.1080/00207454.2019.1645142 · Cited by 31 · see citing works

Imatinib methanesulfonate reduces hyperphosphorylation of tau following repeated peripheral exposure to lipopolysaccharide

Gardner, L. E., White, J. D., Eimerbrink, M. J., Boehm, G. W., & Chumley, M. J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.06.007 · Cited by 29 · see citing works

c-Abl kinase at the crossroads of healthy synaptic remodeling and synaptic dysfunction in neurodegenerative diseases

Gutiérrez, D. A., Chandía-Cristi, A., Yañez, M. J., Zanlungo, S., & Alvarez, A. R. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.346540 · Cited by 30 · see citing works

Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy

Javidnia, M., Hebron, M. L., Xin, Y., Kinney, N. G., & Moussa, C. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170429 · Cited by 29 · see citing works

Finding pathogenic commonalities between Niemann-Pick type C and other lysosomal storage disorders: Opportunities for shared therapeutic interventions

Yañez, M. J., Marín, T., Balboa, E., Klein, A. D., Alvarez, A. R., & Zanlungo, S. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165875 · Cited by 29 · see citing works

Targeting kinases in Parkinson's disease: A mechanism shared by LRRK2, neurotrophins, exenatide, urate, nilotinib and lithium

Guttuso, T. J., Andrzejewski, K. L., Lichter, D. G., & Andersen, J. K. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.05.016 · Cited by 29 · see citing works

Therapeutic Potential of the Hsp90/Cdc37 Interaction in Neurodegenerative Diseases

Gracia, L., Lora, G., Blair, L. J., & Jinwal, U. K. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01263 · Cited by 28 · see citing works

TYK2 regulates tau levels, phosphorylation and aggregation in a tauopathy mouse model

Kim, J., Tadros, B., Liang, Y. H. W., Kim, Y. D., Lasagna‐Reeves, C. A., Sonn, J. Y., Chung, D. C., Hyman, B. T., Holtzman, D. M., & Zoghbi, H. Y. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01777-2 · Cited by 26 · see citing works

p73 haploinsufficiency causes tau hyperphosphorylation and tau kinase dysregulation in mouse models of aging and Alzheimer's disease

Cancino, G. I., Miller, F. D., & Kaplan, D. R. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.04.010 · Cited by 26 · see citing works

The Emerging Role of Cables1 in Cancer and Other Diseases

Huang, J.-R., Tan, G., Li, Y., & Shi, Z. (2017) · Molecular Pharmacology · doi:10.1124/mol.116.107730 · Cited by 24 · see citing works

High-Performance Extended-Gate Field-Effect Transistor for Kinase Sensing in Aβ Accumulation of Alzheimer’s Disease

Peng, Q., Zhang, M., & Shi, G. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.1c05164 · Cited by 23 · see citing works

c-Abl activates RIPK3 signaling in Gaucher disease

Yañez, M. J., Campos, F., Marín, T., Klein, A. D., Futerman, A. H., Alvarez, A. R., & Zanlungo, S. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166089 · Cited by 22 · see citing works

Focusing on cyclin-dependent kinases 5: A potential target for neurological disorders

Tian, Z., Feng, B., Wang, X.-Q., & Tian, J. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1030639 · Cited by 21 · see citing works

The role of probiotics, prebiotics, and postbiotics: cellular and molecular pathways activated on glial cells in Alzheimer’s disease

Patricio-Martínez, A., Patricio, F., Macuil-Chapuli, E., Martínez-Juárez, E. Á., Flores-Díaz, S., Cedillo-Ramirez, M. L., & Limón, I. D. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1598011 · Cited by 22 · see citing works

A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease

Timmons, J. A., Anighoro, A., Brogan, R. J., Stahl, J., Wahlestedt, C., Farquhar, D. G., Taylor‐King, J. P., Volmar, C., Kraus, W. E., & Phillips, S. M. (2021) · eLife · doi:10.7554/elife.68832 · Cited by 21 · see citing works

Chaperoning of specific tau structure by immunophilin FKBP12 regulates the neuronal resilience to extracellular stress

Jiang, L., Chakraborty, P., Zhang, L., Wong, M., Hill, S. E., Webber, C. J., Libera, J., Blair, L. J., Wolozin, B. L., & Zweckstetter, M. (2023) · Science Advances · doi:10.1126/sciadv.add9789 · Cited by 18 · see citing works

c-Abl tyrosine kinase down-regulation as target for memory improvement in Alzheimer’s disease

León-Martínez, R., Gutiérrez, D. A., Pinto, C., Morales, C., de la Fuente, C., Riquelme, C., Cortés, B. I., González-Martín, A., Chamorro, D., Espinosa, N., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1180987 · Cited by 18 · see citing works

Neuroprotective potential of imatinib in global ischemia-reperfusion-induced cerebral injury: possible role of Janus-activated kinase 2/signal transducer and activator of transcription 3 and connexin 43

Wang, J., Bai, T., Wang, N., Li, H., & Guo, X. (2020) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2020.24.1.11 · Cited by 18 · see citing works

Abnormal phosphorylation of protein tyrosine in neurodegenerative diseases

Shu, L., Du, C., & Zuo, Y. (2023) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlad066 · Cited by 17 · see citing works

Altered expression of c-Abl in patients with epilepsy and in a rat model

Chen, L., Wang, Z., Tang, B., Fang, M., Li, J., Chen, G., & Wang, X. (2014) · Synapse · doi:10.1002/syn.21741 · Cited by 15 · see citing works

The c-Abl/p73 pathway induces neurodegeneration in a Parkinson's disease model

Marín, T., Valls, C., Jerez, C., Huerta, T., Elgueta, D., Vidal, R. L., Alvarez, A. R., & Cancino, G. I. (2022) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2022.10.006 · Cited by 14 · see citing works

Abelson Kinases Mediate the Depression of Spontaneous Synaptic Activity Induced by Amyloid Beta 1–42 Peptides

Reichenstein, M., Borovok, N., Sheinin, A., Brider, T., & Michaelevski, I. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00858-7 · Cited by 13 · see citing works

A common molecular and cellular pathway in developing Alzheimer and cancer

Ali, M., Wani, S. U. D., Dey, T., Sridhar, S. B., & QADRIE, Z. L. (2023) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2023.101625 · Cited by 13 · see citing works

c-Abl regulates a synaptic plasticity-related transcriptional program involved in memory and learning

González-Martín, A., Moyano, T. C., Gutiérrez, D. A., Carvajal, F. J., Cerpa, W. F., Hanley, J. G., Gutiérrez, R. A., & Alvarez, A. R. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.102122 · Cited by 12 · see citing works

c-Abl Regulates the Pathological Deposition of TDP-43 via Tyrosine 43 Phosphorylation

Lee, S., Ryu, H. G., Kweon, S. H., Kim, H., Park, H., Lee, K., Jang, S., Na, C. H., Kim, S., & Ko, H. S. (2022) · Cells · doi:10.3390/cells11243972 · Cited by 12 · see citing works

c-Abl Phosphorylates MFN2 to Regulate Mitochondrial Morphology in Cells under Endoplasmic Reticulum and Oxidative Stress, Impacting Cell Survival and Neurodegeneration

Martinez, A. N., Lamaizon, C. M., Valls, C., Llambi, F., Leal, N. R., Fitzgerald, P., Guy, C. S., Kamiński, M. M., Inestrosa, N. C., van Zundert, B., et al. (2023) · Antioxidants · doi:10.3390/antiox12112007 · Cited by 12 · see citing works

c-Abl Tyrosine Kinase Is Required for BDNF-Induced Dendritic Branching and Growth

Chandía-Cristi, A., Stuardo, N., Trejos, C., Leal, N. R., Urrutia, D., Bronfman, F. C., & Rojas, A. Á. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031944 · Cited by 12 · see citing works

The Therapeutic Potential of Flavonols in Alzheimer's Disease: Inhibiting Amyloid‐β, Oxidative Stress, and Neuroinflammation

Zamanian, M. Y., Khachatryan, L., Heidari, M., Darabi, R., Golmohammadi, M., Al-Aouadi, R. F. A., & Akkol, E. K. (2025) · BioFactors · doi:10.1002/biof.70047 · Cited by 11 · see citing works

Cognitive dysfunction after withdrawal of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia

Claudiani, S., Apperley, J. F., Deplano, S., Khorashad, J. S., Foroni, L., Palanicawandar, R., Perry, R. J., & Milojković, D. (2016) · American Journal of Hematology · doi:10.1002/ajh.24495 · Cited by 11 · see citing works

Substrate-Selective Positive Allosteric Modulation of Ptprd's Phosphatase by FlavonolsPreprint

Henderson, I. M., Marez, C., Dokładny, K., Smoake, J., Martinez, M., Johnson, D. K., & Uhl, G. R. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4065674 · Cited by 11 · see citing works

The Hippo signaling pathway as a therapeutic target in Alzheimer’s disease

Chen, D., Wigglesworth-Littlewood, S., & Gunn‐Moore, F. J. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00891-4 · Cited by 10 · see citing works

Roles for c-Abl in postoperative neurodegeneration

Feng, L., Fu, S., Yao, Y., Li, Y., Xu, L., Zhao, Y., & Luo, L. (2022) · International Journal of Medical Sciences · doi:10.7150/ijms.73740 · Cited by 10 · see citing works

Tianma-Gouteng pair ameliorates the cognitive deficits on two transgenic mouse models of Alzheimer's disease

Zhong, M., Xu, Q., Hu, Z. J., Yang, W., Lin, Z., & Xian, Y. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118113 · Cited by 9 · see citing works

Does the small tyrosine kinase inhibitor imatinib mesylate counteract diabetes by affecting pancreatic islet amyloidosis and fibrosis?

Welsh, N. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.724398 · Cited by 9 · see citing works

Unlocking the therapeutic potential of protein kinase inhibitors in neurodegenerative and psychiatric disorders

Angela Asir, R., V, Buzaeva, P., & Michaelevski, I. (2025) · Exploration of Drug Science · doi:10.37349/eds.2025.100892 · Cited by 8 · see citing works

SC75741, A Novel c-Abl Inhibitor, Promotes the Clearance of TDP25 Aggregates via ATG5-Dependent Autophagy Pathway

Zhou, D., Yan, H., Yang, S., Zhang, Y., Xu, X., Cen, X., Lei, K., & Xia, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.741219 · Cited by 8 · see citing works

Role of proline‐rich tyrosine kinase 2 (Pyk2) in the pathogenesis of Alzheimer's disease

Kumar, R. K., Tiwari, V., & Dey, S. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15569 · Cited by 8 · see citing works

Identification of abelson tyrosine kinase inhibitors as potential therapeutics for Alzheimer’s disease using multiple e-pharmacophore modeling and molecular dynamics

Palakurti, R., & Vadrevu, R. (2016) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2016.1166454 · Cited by 7 · see citing works

Repurposing of Kinase Inhibitors to Target c-Abl as Potential Therapeutics for Alzheimer’s Disease

Zhu, Q., Chen, J., Wu, X. L., Jin, X., & Ruan, B. (2014) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-014-9202-5 · Cited by 7 · see citing works

Imatinib in Targeted Therapy: Advances in Biomedical Applications and Drug Delivery Systems

Gvozdeva, Y., Georgieva, P., & Katsarov, P. (2025) · Hemato · doi:10.3390/hemato6040040 · Cited by 5 · see citing works

Hippocampal Aβ expression, but not phosphorylated tau, predicts cognitive deficits following repeated peripheral poly I:C administration

White, J. D., Eimerbrink, M. J., Hayes, H. B., Hardy, A., Enkevort, E. A. V., Peterman, J. L., Chumley, M. J., & Boehm, G. W. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.07.032 · Cited by 5 · see citing works

Propofol inhibits the expression of Abelson nonreceptor tyrosine kinase without affecting learning or memory function in neonatal rats

Feng, L., Sun, Z., Liu, Q., Ma, T., Xu, Z., Feng, Z., Yuan, W., Zhang, H., & Xu, L. (2020) · Brain and Behavior · doi:10.1002/brb3.1810 · Cited by 5 · see citing works

Ptprd deficiency promotes tau hyperphosphorylation and impairs cognitive function in aged mice

Foncea-Bitrán, A., Franchini, N., Tobar, I., Thienel, S., Retamal, I. N., Cancino, G. I., & Cornejo, F. (2025) · Biological Research · doi:10.1186/s40659-025-00607-4 · Cited by 4 · see citing works

Exploring the anti-stress effects of imatinib and tetrabenazine in cold-water immersion-induced acute stress in mice

Kumar, M., Singh, N., & Jaggi, A. S. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01862-w · Cited by 4 · see citing works

The interference between SARS-COV-2 and Alzheimer’s disease: Potential immunological and neurobiological crosstalk from a kinase perspective reveals a delayed pandemic

Mansour, H. M. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102195 · Cited by 3 · see citing works

Hydrogen sulfide in the brain as a silent neuroprotector in Alzheimer’s disease

Layal, H., Rajbongshi, J., Kumar, R., Pandey, S., Mishra, R., & Yadav, P. K. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.08.057 · Cited by 3 · see citing works

What is the Link Between Protein Aggregation and Interneuronal Lesion Propagation in Neurodegenerative Disease?

Garth, F. (2011) · InTech eBooks · doi:10.5772/27973 · Cited by 3 · see citing works

Reciprocal c-Abl-GPx1 regulation controls CA1 neuronal viability to oxidative stress via ERK1/2-DRP1-mediated mitochondrial dynamics

Kim, J.-E., Wang, S. H., & Kang, T. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110586 · Cited by 2 · see citing works

Alzheimer’s disease prevention by flavonols and their analogs

Uhl, G. R., Kannan, B., Choi, J., & Henderson, I. M. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100361 · Cited by 2 · see citing works

P2‐214: c‐Abl kinase activation regulates both the neuronal death and the tau phosphorylation in Alzhemier's disease models

Alvarez, A. R., de Arce, K. P., & Cancino, G. I. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.05.1263

The localization of c-Abl in Alzheimer's disease

Jing, Z. (2008) · D-Scholarship@Pitt (University of Pittsburgh)

STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer's β-amyloid deposits

Cancino, G. I., Toledo, E. M., Leal, N. R., Hernández, D. E., Yévenes, L. F., Inestrosa, N. C., & Alvarez, A. R. (2008) · Brain · doi:10.1093/brain/awn125 · Cited by 147 · see citing works

P1‐160: Neurodegeneration as a consequence of expression of active c‐abl in the adult mouse brain

Schlatterer, S. D., Tremblay, M. A., Acker, C. M., & Davies, P. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.05.710

C-Abl Tyrosine Kinase Signaling: A New Player in AD Tau Pathology

Estrada, L. D., Zanlungo, S., & Alvarez, A. R. (2011) · Current Alzheimer Research · doi:10.2174/156720511796717249 · Cited by 18 · see citing works